Laman Utama068270 • KRX
add
Celltrion Inc
Tutup sebelumnya
₩162,400.00
Julat hari
₩156,300.00 - ₩160,500.00
Julat tahun
₩152,666.67 - ₩200,952.39
Permodalan pasaran
35.75T KRW
Bilangan Purata
451.42K
Nisbah P/E
78.27
Hasil dividen
0.45%
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (KRW) | Dis 2024info | Perubahan T/T |
|---|---|---|
Hasil | 1.06T | 178.01% |
Perbelanjaan pengendalian | 347.40B | 182.95% |
Pendapatan bersih | 236.65B | 22,354.46% |
Margin untung bersih | 22.25 | 7,846.43% |
Pendapatan bagi setiap syer | 1.15K | 13,270.00% |
EBITDA | 275.17B | 201.50% |
Kadar cukai berkesan | 14.02% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (KRW) | Dis 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 1.14T | 50.90% |
Jumlah aset | 21.06T | 5.50% |
Jumlah liabiliti | 3.48T | 22.75% |
Jumlah ekuiti | 17.58T | — |
Syer tertunggak | 215.26J | — |
Harga kepada buku | 2.00 | — |
Pulangan pada aset | 2.37% | — |
Pulangan pada modal | 2.52% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (KRW) | Dis 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 236.65B | 22,354.46% |
Tunai daripada operasi | 305.93B | 104.51% |
Tunai daripada pelaburan | -101.50B | -175.12% |
Tunai daripada pembiayaan | -228.94B | -214.96% |
Perubahan bersih dalam tunai | 23.77B | -88.30% |
Aliran tunai bebas | 61.13B | 103.98% |
Perihal
Celltrion, Inc. is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. Celltrion's founder, Seo Jung-jin, is the richest person in South Korea. Seo Jung-jin, its founder was awarded the 2021 EY World Entrepreneur Of The Year. Wikipedia
CEO
Diasaskan
2002
Tapak web
Pekerja
1,074
